Published in Cell on April 21, 1995
Precision and functional specificity in mRNA decay. Proc Natl Acad Sci U S A (2002) 8.20
The 3' to 5' degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3' to 5' exonucleases of the exosome complex. EMBO J (1998) 7.83
Association of the yeast poly(A) tail binding protein with translation initiation factor eIF-4G. EMBO J (1996) 7.28
Global analysis of mRNA decay and abundance in Escherichia coli at single-gene resolution using two-color fluorescent DNA microarrays. Proc Natl Acad Sci U S A (2002) 6.93
5'-Capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev (1997) 6.68
AU-rich elements and associated factors: are there unifying principles? Nucleic Acids Res (2006) 6.22
Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol Cell Biol (2002) 5.80
When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA (1995) 5.76
A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates. J Cell Biol (1997) 4.93
Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1999) 4.35
Translation initiation factor eIF4G mediates in vitro poly(A) tail-dependent translation. Proc Natl Acad Sci U S A (1997) 3.72
The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs. Genes Dev (1998) 3.71
mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol Cell Biol (1995) 3.61
Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol Cell Biol (1996) 3.58
UTRdb and UTRsite: specialized databases of sequences and functional elements of 5' and 3' untranslated regions of eukaryotic mRNAs. Update 2002. Nucleic Acids Res (2002) 3.57
Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol Cell Biol (1997) 3.54
Messenger RNA deadenylylation precedes decapping in mammalian cells. Proc Natl Acad Sci U S A (1997) 3.51
Hrp1, a sequence-specific RNA-binding protein that shuttles between the nucleus and the cytoplasm, is required for mRNA 3'-end formation in yeast. Genes Dev (1997) 3.47
Rotavirus RNA-binding protein NSP3 interacts with eIF4GI and evicts the poly(A) binding protein from eIF4F. EMBO J (1998) 3.16
Ccr4p is the catalytic subunit of a Ccr4p/Pop2p/Notp mRNA deadenylase complex in Saccharomyces cerevisiae. EMBO J (2002) 3.10
mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol Cell Biol (2000) 3.06
The two proteins Pat1p (Mrt1p) and Spb8p interact in vivo, are required for mRNA decay, and are functionally linked to Pab1p. Mol Cell Biol (2000) 3.00
Isolation and characterization of Dcp1p, the yeast mRNA decapping enzyme. EMBO J (1998) 2.82
Analysis of recombinant yeast decapping enzyme. RNA (2003) 2.50
Statistical analysis of yeast genomic downstream sequences reveals putative polyadenylation signals. Nucleic Acids Res (2000) 2.50
The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J (1998) 2.49
Rat1p and Xrn1p are functionally interchangeable exoribonucleases that are restricted to and required in the nucleus and cytoplasm, respectively. Mol Cell Biol (1997) 2.40
A broader role for AU-rich element-mediated mRNA turnover revealed by a new transcriptional pulse strategy. Nucleic Acids Res (1998) 2.31
Ataxin-2 interacts with the DEAD/H-box RNA helicase DDX6 and interferes with P-bodies and stress granules. Mol Biol Cell (2007) 2.30
PAN3 encodes a subunit of the Pab1p-dependent poly(A) nuclease in Saccharomyces cerevisiae. Mol Cell Biol (1996) 2.30
DNA methylation inhibits elongation but not initiation of transcription in Neurospora crassa. Genes Dev (1997) 2.16
Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol Cell Biol (2000) 2.12
EDEN and EDEN-BP, a cis element and an associated factor that mediate sequence-specific mRNA deadenylation in Xenopus embryos. EMBO J (1998) 2.10
Novel Upf2p orthologues suggest a functional link between translation initiation and nonsense surveillance complexes. Mol Cell Biol (2000) 2.07
Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells. Mol Cell Biol (1997) 2.04
UTRdb and UTRsite: specialized databases of sequences and functional elements of 5' and 3' untranslated regions of eukaryotic mRNAs. Nucleic Acids Res (2000) 2.02
The herpes simplex virus vhs protein induces endoribonucleolytic cleavage of target RNAs in cell extracts. J Virol (1999) 1.96
Cap-dependent deadenylation of mRNA. EMBO J (2000) 1.96
Crystal structure of mammalian poly(A) polymerase in complex with an analog of ATP. EMBO J (2000) 1.96
Chloroplast mRNA 3'-end processing by a high molecular weight protein complex is regulated by nuclear encoded RNA binding proteins. EMBO J (1996) 1.95
Analysis of mutations in the yeast mRNA decapping enzyme. Genetics (1999) 1.93
mRNA surveillance in eukaryotes: kinetic proofreading of proper translation termination as assessed by mRNP domain organization? RNA (1999) 1.89
Stability of a PKCI-1-related mRNA is controlled by the splicing factor ASF/SF2: a novel function for SR proteins. Genes Dev (2002) 1.89
Recognition of yeast mRNAs as "nonsense containing" leads to both inhibition of mRNA translation and mRNA degradation: implications for the control of mRNA decapping. Mol Biol Cell (1999) 1.88
A multiplicity of coactivators is required by Gcn4p at individual promoters in vivo. Mol Cell Biol (2003) 1.88
The stem-loop binding protein is required for efficient translation of histone mRNA in vivo and in vitro. Mol Cell Biol (2002) 1.84
Direct observation of specific messenger RNA in a single living cell under a fluorescence microscope. Biophys J (2000) 1.83
Identification of AUF1 (heterogeneous nuclear ribonucleoprotein D) as a component of the alpha-globin mRNA stability complex. Mol Cell Biol (1997) 1.83
Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J (1998) 1.83
RNase MRP cleaves the CLB2 mRNA to promote cell cycle progression: novel method of mRNA degradation. Mol Cell Biol (2004) 1.81
Oligoribonuclease is an essential component of the mRNA decay pathway. Proc Natl Acad Sci U S A (1999) 1.79
Computational modeling of eukaryotic mRNA turnover. RNA (2001) 1.79
Two different RNA binding activities for the AU-rich element and the poly(A) sequence of the mouse neuronal protein mHuC. Nucleic Acids Res (1996) 1.77
Identification of a novel human nuclear-encoded mitochondrial poly(A) polymerase. Nucleic Acids Res (2004) 1.73
The poly(A) tail inhibits the assembly of a 3'-to-5' exonuclease in an in vitro RNA stability system. Mol Cell Biol (1997) 1.71
Multi-locus selection and the structure of variation at the white gene of Drosophila melanogaster. Genetics (1996) 1.70
A systematic approach to reconstructing transcription networks in Saccharomycescerevisiae. Proc Natl Acad Sci U S A (2002) 1.70
Mechanisms of deadenylation-dependent decay. Wiley Interdiscip Rev RNA (2010) 1.69
microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS One (2009) 1.67
Assembly of the alpha-globin mRNA stability complex reflects binary interaction between the pyrimidine-rich 3' untranslated region determinant and poly(C) binding protein alphaCP. Mol Cell Biol (1999) 1.66
The final step in the formation of 25S rRNA in Saccharomyces cerevisiae is performed by 5'-->3' exonucleases. RNA (2000) 1.65
Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA (2001) 1.64
Conventional and unconventional mechanisms for capping viral mRNA. Nat Rev Microbiol (2011) 1.61
Rapid deadenylation triggered by a nonsense codon precedes decay of the RNA body in a mammalian cytoplasmic nonsense-mediated decay pathway. Mol Cell Biol (2003) 1.60
Global role of TATA box-binding protein recruitment to promoters in mediating gene expression profiles. Mol Cell Biol (2004) 1.58
The BTG2 protein is a general activator of mRNA deadenylation. EMBO J (2008) 1.54
UNR, a new partner of poly(A)-binding protein, plays a key role in translationally coupled mRNA turnover mediated by the c-fos major coding-region determinant. Genes Dev (2004) 1.52
Upf1p, Nmd2p, and Upf3p regulate the decapping and exonucleolytic degradation of both nonsense-containing mRNAs and wild-type mRNAs. Mol Cell Biol (2001) 1.50
Functional analysis of yeast snoRNA and snRNA 3'-end formation mediated by uncoupling of cleavage and polyadenylation. Mol Cell Biol (2002) 1.49
Recognition of polyadenosine RNA by zinc finger proteins. Proc Natl Acad Sci U S A (2007) 1.43
Structure and function of a cap-independent translation element that functions in either the 3' or the 5' untranslated region. RNA (2000) 1.42
The cleavage and polyadenylation specificity factor in Xenopus laevis oocytes is a cytoplasmic factor involved in regulated polyadenylation. Mol Cell Biol (1999) 1.41
Splicing and 3' end formation in the definition of nonsense-mediated decay-competent human beta-globin mRNPs. EMBO J (2001) 1.41
Polyadenylation accelerates degradation of chloroplast mRNA. EMBO J (1996) 1.40
The enhancer of decapping proteins, Edc1p and Edc2p, bind RNA and stimulate the activity of the decapping enzyme. RNA (2003) 1.39
The poly(A)-binding protein and an mRNA stability protein jointly regulate an endoribonuclease activity. Mol Cell Biol (2000) 1.39
mRNA instability elements in the human papillomavirus type 16 L2 coding region. J Virol (1998) 1.39
Cleavage of RNA hairpins mediated by a developmentally regulated CCCH zinc finger protein. Mol Cell Biol (1996) 1.38
Identification of the RNA-binding, dimerization, and eIF4GI-binding domains of rotavirus nonstructural protein NSP3. J Virol (1999) 1.37
Nonsense-mediated decay of human HEXA mRNA. Mol Cell Biol (2001) 1.35
Npl3 is an antagonist of mRNA 3' end formation by RNA polymerase II. EMBO J (2005) 1.34
Novel functional role of CA repeats and hnRNP L in RNA stability. RNA (2003) 1.33
A ribonuclease specific for inosine-containing RNA: a potential role in antiviral defence? EMBO J (1997) 1.30
Deciphering the cellular pathway for transport of poly(A)-binding protein II. RNA (2000) 1.29
Fip1 regulates the activity of Poly(A) polymerase through multiple interactions. Mol Cell Biol (2001) 1.27
The target of rapamycin signaling pathway regulates mRNA turnover in the yeast Saccharomyces cerevisiae. Mol Biol Cell (2001) 1.27
mRNA turnover in yeast promoted by the MATalpha1 instability element. Nucleic Acids Res (1996) 1.26
UTRdb: a specialized database of 5' and 3' untranslated regions of eukaryotic mRNAs. Nucleic Acids Res (1999) 1.26
The 5' and 3' TAR elements of human immunodeficiency virus exert effects at several points in the virus life cycle. J Virol (1998) 1.25
The mechanism and regulation of deadenylation: identification and characterization of Xenopus PARN. RNA (2001) 1.25
Premature termination codons enhance mRNA decapping in human cells. Nucleic Acids Res (2004) 1.24
Modifications of the 5' cap of mRNAs during Xenopus oocyte maturation: independence from changes in poly(A) length and impact on translation. Mol Cell Biol (1998) 1.23
Multiple steps in the regulation of transcription-factor level and activity. Biochem J (1996) 1.23
Genetic analysis of glucose regulation in saccharomyces cerevisiae: control of transcription versus mRNA turnover. EMBO J (1996) 1.23
Mutations in VPS16 and MRT1 stabilize mRNAs by activating an inhibitor of the decapping enzyme. Mol Cell Biol (1999) 1.23
Mutational analysis of the virion host shutoff gene (UL41) of herpes simplex virus (HSV): characterization of HSV type 1 (HSV-1)/HSV-2 chimeras. J Virol (1997) 1.22
The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein. J Virol (1999) 1.21
RNA polymerase I-promoted HIS4 expression yields uncapped, polyadenylated mRNA that is unstable and inefficiently translated in Saccharomyces cerevisiae. Mol Cell Biol (1998) 1.21
A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev (1993) 9.28
A rapid method for localized mutagenesis of yeast genes. Yeast (1992) 7.79
Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'-->3' digestion of the transcript. Genes Dev (1994) 7.57
An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature (1996) 6.15
Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell (1987) 6.08
Premature translational termination triggers mRNA decapping. Nature (1994) 6.05
Yeast Sm-like proteins function in mRNA decapping and decay. Nature (2000) 5.95
The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell (2001) 5.86
Turnover mechanisms of the stable yeast PGK1 mRNA. Mol Cell Biol (1995) 5.83
Identification and comparison of stable and unstable mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1990) 5.47
The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J (1999) 5.08
The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA (2001) 4.80
Yeast exosome mutants accumulate 3'-extended polyadenylated forms of U4 small nuclear RNA and small nucleolar RNAs. Mol Cell Biol (2000) 4.57
Mutations in translation initiation factors lead to increased rates of deadenylation and decapping of mRNAs in Saccharomyces cerevisiae. Mol Cell Biol (1999) 4.35
Mechanisms and control of mRNA turnover in Saccharomyces cerevisiae. Microbiol Rev (1996) 4.34
Mutations affecting stability and deadenylation of the yeast MFA2 transcript. Genes Dev (1992) 4.20
Multiple functions for the poly(A)-binding protein in mRNA decapping and deadenylation in yeast. Genes Dev (1995) 4.15
Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol Cell (2001) 4.12
A small segment of the MAT alpha 1 transcript promotes mRNA decay in Saccharomyces cerevisiae: a stimulatory role for rare codons. Mol Cell Biol (1993) 3.91
Quality control of mRNA 3'-end processing is linked to the nuclear exosome. Nature (2001) 3.69
Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol Cell Biol (1996) 3.58
The Puf3 protein is a transcript-specific regulator of mRNA degradation in yeast. EMBO J (2000) 3.38
Differential effects of translational inhibition in cis and in trans on the decay of the unstable yeast MFA2 mRNA. J Biol Chem (1994) 3.37
Mutations in conserved intron sequences affect multiple steps in the yeast splicing pathway, particularly assembly of the spliceosome. EMBO J (1986) 3.35
mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol Cell Biol (2000) 3.06
Mechanisms of mRNA degradation in eukaryotes. Trends Biochem Sci (1994) 2.96
Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med (1987) 2.91
Isolation and characterization of Dcp1p, the yeast mRNA decapping enzyme. EMBO J (1998) 2.82
Mechanisms of mRNA surveillance in eukaryotes. Annu Rev Genet (1999) 2.73
The exosome: a proteasome for RNA? Cell (1999) 2.72
Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol Cell Biol (2000) 2.71
Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol (1995) 2.69
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. Biochem Pharmacol (1996) 2.67
Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae. Annu Rev Biochem (2000) 2.66
Changes in tonsillectomy rates associated with feedback and review. Pediatrics (1977) 2.60
A point mutation in the conserved hexanucleotide at a yeast 5' splice junction uncouples recognition, cleavage, and ligation. Cell (1985) 2.56
The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer (2007) 2.48
Three conserved members of the RNase D family have unique and overlapping functions in the processing of 5S, 5.8S, U4, U5, RNase MRP and RNase P RNAs in yeast. EMBO J (2000) 2.44
Analysis of the yeast genome: identification of new non-coding and small ORF-containing RNAs. Nucleic Acids Res (1997) 2.40
Measurement of mRNA decay rates in Saccharomyces cerevisiae. Methods Enzymol (1991) 2.17
Aberrant mRNAs with extended 3' UTRs are substrates for rapid degradation by mRNA surveillance. RNA (1999) 2.15
Functions of Lsm proteins in mRNA degradation and splicing. Curr Opin Cell Biol (2000) 2.14
Diversity of cytoplasmic functions for the 3' untranslated region of eukaryotic transcripts. Curr Opin Cell Biol (1995) 2.06
A trans-acting suppressor restores splicing of a yeast intron with a branch point mutation. Genes Dev (1987) 1.99
Chemotherapy plus local treatment in the management of intraocular retinoblastoma. Arch Ophthalmol (1996) 1.95
Analysis of mutations in the yeast mRNA decapping enzyme. Genetics (1999) 1.93
mRNA surveillance in eukaryotes: kinetic proofreading of proper translation termination as assessed by mRNP domain organization? RNA (1999) 1.89
Recognition of yeast mRNAs as "nonsense containing" leads to both inhibition of mRNA translation and mRNA degradation: implications for the control of mRNA decapping. Mol Biol Cell (1999) 1.88
Functional evaluation following microvascular oromandibular reconstruction of the oral cancer patient: a comparative study of reconstructed and nonreconstructed patients. Laryngoscope (1991) 1.85
Separation of the mixture of trehalose 6,6'-dimycolates comprising the mycobacterial glycolipid fraction, "P3". Biochem Biophys Res Commun (1977) 1.82
Two related proteins, Edc1p and Edc2p, stimulate mRNA decapping in Saccharomyces cerevisiae. Genetics (2001) 1.80
Computational modeling of eukaryotic mRNA turnover. RNA (2001) 1.79
The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase. Biochem J (1969) 1.76
Defects in the mRNA export factors Rat7p, Gle1p, Mex67p, and Rat8p cause hyperadenylation during 3'-end formation of nascent transcripts. RNA (2001) 1.71
Detection of Trichomonas vaginalis in pregnant women with the InPouch TV culture system. J Clin Microbiol (1993) 1.68
Time trends in incidence rates of first hip fracture in the Uppsala Health Care Region, Sweden, 1965-1983. Am J Epidemiol (1989) 1.62
The medical management of a heroin epidemic. Arch Gen Psychiatry (1972) 1.59
The yeast cytoplasmic LsmI/Pat1p complex protects mRNA 3' termini from partial degradation. Genetics (2001) 1.57
Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol (1994) 1.57
Performance measures in three rounds of the English bowel cancer screening pilot. Gut (2011) 1.52
Analysis of chimeric mRNAs derived from the STE3 mRNA identifies multiple regions within yeast mRNAs that modulate mRNA decay. Nucleic Acids Res (1992) 1.51
Epidemiologic features of Strongyloides stercoralis infection in an endemic area of the United States. Am J Trop Med Hyg (1982) 1.49
Local impact of the English arm of the UK Bowel Cancer Screening Pilot study. Br J Surg (2008) 1.42
Ritualised self harm in traditional aboriginal society. Aust N Z J Psychiatry (1994) 1.39
Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines. Mol Cell Biol (1992) 1.39
Postoperative radiation therapy after radical prostatectomy for prostate carcinoma. Cancer (1992) 1.38
Orientation-dependent function of a short CYC1 DNA fragment in directing mRNA 3' end formation in yeast. Proc Natl Acad Sci U S A (1988) 1.32
mRNA turnover in yeast promoted by the MATalpha1 instability element. Nucleic Acids Res (1996) 1.26
A multivariate analysis of factors associated with depression: evaluating the role of health literacy as a potential contributor. Arch Intern Med (2000) 1.26
Ability, achievement, and adjustment in homeless children. Am J Orthopsychiatry (1991) 1.25
A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen (2001) 1.25
Modelling potential impacts of bottom trawl fisheries on soft sediment biogeochemistry in the North Sea. Geochem Trans (2001) 1.21
Effects of mutations in the Saccharomyces cerevisiae RNA14, RNA15, and PAP1 genes on polyadenylation in vivo. Mol Cell Biol (1995) 1.20
Biologically active components from mycobacterial cell walls. IV. Protection of mice against aerosol infection with virulent mycobacterium tuberculosis. Cell Immunol (1975) 1.20
Surgical management of ventricular tachycardia in subannular left ventricular aneurysm. Ann Thorac Surg (1995) 1.16
Simplified scoring and psychometrics of the revised 12-item Short-Form Health Survey. Outcomes Manag Nurs Pract (2002) 1.14
TGF-beta in intestinal lymphoid organs contributes to the death of armed effector CD8 T cells and is associated with the absence of virus containment in rhesus macaques infected with the simian immunodeficiency virus. Cell Death Differ (2007) 1.14
Computational identification of cis-acting elements affecting post-transcriptional control of gene expression in Saccharomyces cerevisiae. Nucleic Acids Res (2000) 1.14
A stochastic and deterministic model of medical care utilization. Health Serv Res (1970) 1.10
Effect of water as a diluent on the glass transition behaviour of malto-oligosaccharides, amylose and amylopectin. Int J Biol Macromol (1989) 1.08
RNA turnover: the helicase story unwinds. Curr Biol (1996) 1.08
Sexual practices and attitudes of street youth in Belo Horizonte, Brazil. Street Youth Study Group. Soc Sci Med (1993) 1.07
Moieties of mycobacterial mycolates required for inducing granulomatous reactions. Cell Immunol (1978) 1.06
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine (2000) 1.05
Activation of a cryptic TACTAAC box in the Saccharomyces cerevisiae actin intron. Mol Cell Biol (1986) 1.05
Tn3 encodes a site-specific recombination system: identification of essential sequences, genes, and the actual site of recombination. Cold Spring Harb Symp Quant Biol (1981) 1.04
Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. South Med J (1992) 1.03
The effect of allograft meniscal replacement on intraarticular contact area and pressures in the human knee. A biomechanical study. Am J Sports Med (1997) 1.03
A comparison of a discriminant versus a clustering analysis of a patient classification for chronic disease care. Med Care (1974) 1.03
The quantitative determination of hypoxanthine and xanthine ("oxypurines") in skeletal muscle from two patients with congenital xanthine oxidase deficiency (xanthinuria). Biochem J (1970) 1.03
Aortic cannulation. Thorax (1969) 1.02
Preservation of isolated heart for 72 hours. Br Med J (1968) 1.02
Advancing newborn health: The Saving Newborn Lives initiative. Glob Public Health (2010) 1.00
Effect of cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci (1980) 1.00
Optimal management of amiodarone therapy: efficacy and side effects. Pharmacotherapy (1999) 0.99
Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials. Immunology (1982) 0.98
European vestibular experiments on the Spacelab-1 mission: 3. Caloric nystagmus in microgravity. Exp Brain Res (1986) 0.96
Yeast mRNA decapping enzyme. Methods Enzymol (2001) 0.95
Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am J Clin Nutr (1990) 0.95